Charles Schwab’s Marrone Bio Innovations, Inc. MBII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-62,408
| Closed | -$73K | – | 3601 |
|
|
2022
Q2 | $73K | Sell |
62,408
-235,688
| -79% | -$246K | ﹤0.01% | 3329 |
|
|
2022
Q1 | $322K | Buy |
298,096
+85,771
| +40% | +$64.8K | ﹤0.01% | 3204 |
|
|
2021
Q4 | $153K | Hold |
212,325
| – | – | ﹤0.01% | 3399 |
|
|
2021
Q3 | $192K | Sell |
212,325
-45,317
| -18% | -$54.5K | ﹤0.01% | 3335 |
|
|
2021
Q2 | $428K | Buy |
257,642
+67,482
| +35% | +$113K | ﹤0.01% | 3198 |
|
|
2021
Q1 | $398K | Buy |
190,160
+17,587
| +10% | +$36.5K | ﹤0.01% | 3156 |
|
|
2020
Q4 | $216K | Hold |
172,573
| – | – | ﹤0.01% | 3249 |
|
|
2020
Q3 | $211K | Hold |
172,573
| – | – | ﹤0.01% | 3163 |
|
|
2020
Q2 | $202K | Buy |
172,573
+43,127
| +33% | +$39.9K | ﹤0.01% | 3167 |
|
|
2020
Q1 | $106K | Buy |
129,446
+16
| +0% | +$17 | ﹤0.01% | 3106 |
|
|
2019
Q4 | $131K | Hold |
129,430
| – | – | ﹤0.01% | 3082 |
|
|
2019
Q3 | $183K | Hold |
129,430
| – | – | ﹤0.01% | 3050 |
|
|
2019
Q2 | $195K | Hold |
129,430
| – | – | ﹤0.01% | 3090 |
|
|
2019
Q1 | $199K | Buy |
129,430
+27,730
| +27% | +$42.3K | ﹤0.01% | 3022 |
|
|
2018
Q4 | $150K | Hold |
101,700
| – | – | ﹤0.01% | 3055 |
|
|
2018
Q3 | $187K | Hold |
101,700
| – | – | ﹤0.01% | 3082 |
|
|
2018
Q2 | $188K | Buy |
+101,700
| New | +$189K | ﹤0.01% | 3070 |
|
|
2015
Q2 | – | Sell |
-16,800
| Closed | -$66K | – | 3145 |
|
|
2015
Q1 | $66K | Hold |
16,800
| – | – | ﹤0.01% | 3052 |
|
|
2014
Q4 | $61K | Hold |
16,800
| – | – | ﹤0.01% | 3080 |
|
|
2014
Q3 | $45K | Hold |
16,800
| – | – | ﹤0.01% | 3056 |
|
|
2014
Q2 | $196K | Buy |
+16,800
| New | +$190K | ﹤0.01% | 3001 |
|
Charles Schwab's MBII Position: Q3 2022 in Review
Charles Schwab sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 62,408 shares — an estimated $73K sold.
Charles Schwab first reported a position in MBII in Q2 2014 and held it in 21 quarters. The position peaked at $428K in Q2 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.
- Charles Schwab reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
- Charles Schwab sold 62,408 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $73K.
- Charles Schwab first reported a position in Marrone Bio Innovations, Inc. in Q2 2014 and held it in 21 quarters.
- Charles Schwab's Marrone Bio Innovations, Inc. position peaked at $428K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.
Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.